Loading...
OTCM
CHGCY
Market cap70bUSD
Sep 17, Last price  
21.40USD
1D
4.19%
1Q
-8.70%
Jan 2017
333.49%
Name

Chugai Pharmaceutical Co Ltd

Chart & performance

D1W1MN
OTCM:CHGCY chart
P/E
25.31
P/S
8.73
EPS
263.71
Div yield, %
4.14%
Shrs. gr., 5y
0.01%
Rev. gr., 5y
9.84%
Revenues
1.26t
+7.46%
326,109,000,000344,808,000,000326,937,000,000428,947,000,000379,509,000,000373,516,000,000386,552,000,000423,652,000,000461,109,000,000498,839,000,000491,780,000,000534,199,000,000579,787,000,000686,184,000,000786,945,000,000999,758,000,0001,259,946,000,0001,111,367,000,0001,170,611,000,0001,257,941,000,000
Net income
434.01b
+12.06%
38,417,000,00040,060,000,00039,265,000,00056,634,000,00041,433,000,00035,234,000,00048,205,000,00050,895,000,00050,980,000,00061,125,000,00053,592,000,00072,713,000,00092,488,000,000157,560,000,000214,733,000,000302,995,000,000374,429,000,000325,472,000,000387,317,000,000434,012,000,000
CFO
389.45b
-12.99%
40,538,000,00060,364,000,00039,277,000,00066,461,000,00015,572,000,00069,593,000,00077,299,000,00053,521,000,00037,034,000,00062,918,000,00038,787,000,000107,623,000,000119,074,000,000206,641,000,000205,035,000,000279,626,000,000244,112,000,000409,925,000,000447,600,000,000389,451,000,000
Dividend
Dec 29, 20260.21121 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. Its operations are carried out through the Domestic and Overseas businesses. The Domestic Business covers the manufacturing, research, and development operations in Japan. The Overseas business comprises of sales and production in Europe, Taiwan and China. The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo, Japan.

Key people

Masayuki Oku
Independent Director · since 2015
URL
https://www.chugai-pharm.co.jp/
IPO date
Mar 03, 1956
Employees
7,771
Domiciled in
JP
Incorporated in
JP
Headquarters & legal address
北区浮間５丁目５番１号
東京都, 13 115-0051
JP
Other language
Chugai Pharmaceutical Co., Ltd.

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT